These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2567265)

  • 1. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
    Chiverton SG; Burget DW; Hunt RH
    Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482.
    Wilder-Smith CH; Merki HS
    Scand J Gastroenterol; 1991 May; 26(5):501-7. PubMed ID: 1678550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
    Rogers MJ; Holmfield JH; Primrose JN; Johnston D
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
    Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
    Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-hour acid suppression profile of nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
    Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring.
    Palasciano G; Maggi V; Portincasa P
    Ital J Gastroenterol; 1990 Oct; 22(5):291-4. PubMed ID: 1983712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
    Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
    Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man.
    Boyd EJ; Wormsley KG
    Eur J Clin Pharmacol; 1984; 26(4):443-7. PubMed ID: 6145595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Wy-45,727 on 24 h intragastric acidity in twenty normal volunteers.
    Merki HS; Kaufmann D; Kempf M; Mappes A; Heim J; Roehmel J; Walt RP
    Br J Clin Pharmacol; 1989 Feb; 27(2):135-8. PubMed ID: 2565728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.
    Brozinsky S; Hogan DL; Isenberg JI; Richardson CT
    Dig Dis Sci; 1984 Feb; 29(2):129-33. PubMed ID: 6141898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
    Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
    World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
    Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
    Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 75 mg HOE 760, a novel H2-receptor antagonist, on daytime peptone-stimulated and nocturnal gastric acid output in healthy volunteers.
    Hagenmüller F; Weber C; Hausmann S; Labs R; Malerczyk V; de Looze S; Classen M
    Scand J Gastroenterol; 1987 Jun; 22(5):609-14. PubMed ID: 2888185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U; Wagner S; Sieberth HG; Klotz U
    Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.